Focus
nirsevimab
FDA Approved Nearly 50 Percent More Drugs in 2023 Than in 2022
Only 2018 featured a higher number of drug approvals.
CDC Issues Alert on Shortage of Key Children’s Medication
The CDC sent a health alert over a shortage of nirsevimab, used to treat RSV.
